Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

IgA nephropathy
Eleni Stamellou, Claudia Seikrit, Sydney C.W. Tang, et al.
Nature Reviews Disease Primers (2023) Vol. 9, Iss. 1
Closed Access | Times Cited: 73

Showing 1-25 of 73 citing articles:

Glycosylation: mechanisms, biological functions and clinical implications
Mengyuan He, Xiangxiang Zhou, Xin Wang
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 33
Multiscale topology classifies cells in subcellular spatial transcriptomics
Katherine Benjamin, Aneesha Bhandari, Jessica D. Kepple, et al.
Nature (2024) Vol. 630, Iss. 8018, pp. 943-949
Open Access | Times Cited: 17
Targeted modulation of intestinal barrier and mucosal immune-related microbiota attenuates IgA nephropathy progression
Ran Zhang, Yuyan Tang, Xiangru Feng, et al.
Gut Microbes (2025) Vol. 17, Iss. 1
Open Access | Times Cited: 2
Exploring Novel Adverse Events of Nefecon
Jingyu Wang, Zhao Zhang, Xingzi Liu, et al.
Kidney International Reports (2024) Vol. 9, Iss. 9, pp. 2705-2717
Open Access | Times Cited: 10
The pathogenesis of IgA nephropathy and implications for treatment
Chee Kay Cheung, Suceena Alexander, Heather N. Reich, et al.
Nature Reviews Nephrology (2024)
Closed Access | Times Cited: 8
Efficacy and safety of Kunxian in IgA nephropathy
Yang Yang, Xiang Li, Honghong Zou, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access | Times Cited: 1
Circulating Proteins and IgA Nephropathy
Chen Tang, Pei Chen, Linlin Xu, et al.
Journal of the American Society of Nephrology (2024) Vol. 35, Iss. 8, pp. 1045-1057
Closed Access | Times Cited: 7
Serum Cytokine Profile in IgA Nephropathy
Friederike Selbach, Umberto Maggiore, Micaela Gentile, et al.
Kidney Medicine (2025) Vol. 7, Iss. 2, pp. 100940-100940
Closed Access
UF-5000 urinary erythrocyte parameters versus urinary aberrant erythrocytes and acanthocytes for diagnosing IgA glomerular hematuria
Shuangshuang Lv, Yifang Ma, Xiaxuan Hu, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
The beneficial effect of adding belimumab in severe and refractory IgA nephropathy: a case report
Youying Mao, Chenxing Zhang, Jing Xu, et al.
Pediatric Nephrology (2025)
Closed Access
Prevention and Treatment of IgA Nephropathy Based on Lung-Intestinal Axis and Mucosal Immunity
静 王
Advances in Clinical Medicine (2025) Vol. 15, Iss. 01, pp. 296-303
Closed Access
Integrated analysis of ATAC-seq and RNA-seq reveals the chromatin accessibility and transcriptional landscape of immunoglobulin a nephropathy
Zhao-Xing Gao, Fang Yang, Shu-Zhen Xu, et al.
Clinical Immunology (2025) Vol. 272, pp. 110432-110432
Closed Access
Single-Cell RNA-Sequencing Analysis Provides Insights into IgA Nephropathy
Ming Xia, Yifu Li, Yu Liu, et al.
Biomolecules (2025) Vol. 15, Iss. 2, pp. 191-191
Open Access
Treatment of Patients with IgA Nephropathy: A call for a new paradigm
Jürgen Floege, Amélie Bernier-Jean, Jonathan Barratt, et al.
Kidney International (2025)
Open Access
Characteristics, pathogenic and therapeutic role of gut microbiota in immunoglobulin A nephropathy
Kaijin Yao, Lingqian Zheng, Wen‐Ming Chen, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Incidence and pathological features of IgA nephropathy before and during the COVID-19 pandemic
Wen Liu, Ricong Xu, Di Wu, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Real-world assessment of sparsentan’s drug safety framework
Wenjing Fu, Jingyu Wang, Yuzhou Xue, et al.
Renal Failure (2025) Vol. 47, Iss. 1
Open Access
Identification of Potential Drug Targets for Immunoglobulin A Nephropathy: A Mendelian Randomization Study
Limei Xiong, Hui Zhang, Yannan Guo, et al.
Biomedicines (2025) Vol. 13, Iss. 3, pp. 581-581
Open Access
IgA nephropathy and IgA vasculitis in a pediatric Crohn’s disease patient with early IgA deposition in vascular walls of intestines
Jianxia Tang, Lan Wang, Wei Zhou, et al.
CEN Case Reports (2025)
Closed Access
Inflammation in glomerular diseases
Yulong Xiong, Wei Li, Songzhi Jin, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
IgA Nephropathy: Epidemiology and Disease Risk Across the World
Malak Ghaddar, Mark Canney, Sean J. Barbour
Seminars in Nephrology (2025), pp. 151564-151564
Open Access
The Genetics of IgA Nephropathy: Implications for Future Therapies
Shufeng Zhou, Hong Zhang
Seminars in Nephrology (2025), pp. 151567-151567
Closed Access
The Journey to Advocacy: Celebrating the IgA Nephropathy Foundation's 20th Anniversary
Brian Parlato
Seminars in Nephrology (2025), pp. 151575-151575
Open Access
Effectiveness and safety of finerenone in non-diabetic patients with IgA nephropathy
Chen Tang, Feng‐Lei Si, Pei Chen, et al.
Journal of Nephrology (2025)
Closed Access
Urine Metabolomics Reveals the Intervention Effects and Mechanism of Shenhua Tablets in IgA Nephropathy
Yuhang Wang, Ping Li, Fengting Yin, et al.
Biomedical Chromatography (2025) Vol. 39, Iss. 5
Closed Access
Page 1 - Next Page

Scroll to top